In contrast, there was no difference in anti-GPIIb/IIIa antibody-producing B cells between the non-ITP disease controls, including aplastic anemia and MDS, and healthy controls. This evidence concerns the gene ITGA2B and autoimmune thrombocytopenic purpura.